The Procter & Gamble Company (NYSE:PG) Stake Cut by Helen Stephens Group LLC

Helen Stephens Group LLC reduced its holdings in The Procter & Gamble Company (NYSE:PGFree Report) by 5.2% in the 3rd quarter, Holdings Channel reports. The fund owned 3,111 shares of the company’s stock after selling 172 shares during the period. Helen Stephens Group LLC’s holdings in Procter & Gamble were worth $539,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of the company. Itau Unibanco Holding S.A. acquired a new position in shares of Procter & Gamble during the 2nd quarter valued at about $28,000. Fairway Wealth LLC acquired a new position in shares of Procter & Gamble during the 2nd quarter valued at about $29,000. Transcendent Capital Group LLC acquired a new position in shares of Procter & Gamble during the 4th quarter valued at about $31,000. Ruedi Wealth Management Inc. increased its holdings in shares of Procter & Gamble by 64.7% during the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after acquiring an additional 77 shares during the last quarter. Finally, POM Investment Strategies LLC acquired a new position in shares of Procter & Gamble during the 2nd quarter valued at about $34,000. 65.77% of the stock is owned by institutional investors and hedge funds.

Procter & Gamble Trading Up 0.6 %

NYSE:PG opened at $168.16 on Wednesday. The firm has a market capitalization of $396.88 billion, a price-to-earnings ratio of 27.48, a PEG ratio of 3.73 and a beta of 0.41. The Procter & Gamble Company has a 1-year low of $141.60 and a 1-year high of $177.94. The business’s 50-day moving average price is $171.09 and its two-hundred day moving average price is $166.58. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.51.

Procter & Gamble (NYSE:PGGet Free Report) last issued its earnings results on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, beating the consensus estimate of $1.37 by $0.03. The firm had revenue of $20.53 billion during the quarter, compared to the consensus estimate of $20.69 billion. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The business’s quarterly revenue was down .1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.37 earnings per share. On average, equities analysts expect that The Procter & Gamble Company will post 6.97 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a yield of 2.39%. Procter & Gamble’s payout ratio is 65.69%.

Insiders Place Their Bets

In related news, CFO Andre Schulten sold 13,041 shares of the firm’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the sale, the chief financial officer now directly owns 37,208 shares in the company, valued at $6,325,360. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, CFO Andre Schulten sold 13,041 shares of the stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the transaction, the chief financial officer now directly owns 37,208 shares in the company, valued at approximately $6,325,360. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Balaji Purushothaman sold 8,842 shares of the business’s stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the sale, the insider now owns 11,537 shares in the company, valued at $1,902,451.30. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 383,194 shares of company stock worth $65,140,718 over the last ninety days. 0.17% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several brokerages recently weighed in on PG. Evercore ISI increased their target price on Procter & Gamble from $177.00 to $183.00 and gave the company an “outperform” rating in a research note on Thursday, July 18th. Piper Sandler began coverage on Procter & Gamble in a research note on Tuesday, September 24th. They set a “neutral” rating and a $174.00 target price for the company. Dbs Bank downgraded Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 1st. JPMorgan Chase & Co. raised their price objective on Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research report on Thursday, September 19th. Finally, Barclays downgraded Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective for the company. in a research report on Monday, September 30th. Nine analysts have rated the stock with a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, Procter & Gamble currently has an average rating of “Moderate Buy” and a consensus price target of $175.89.

Check Out Our Latest Stock Analysis on Procter & Gamble

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Recommended Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.